A c c e p t e d M a n u s c r i p t M a n u s c r i p t
Introduction
Worldwide, ever increasing numbers of bacterial clinical isolates are being reported with resistance to therapeutically relevant antibiotics. This trend is set against a backdrop of diminished development of novel antibiotics, particularly those with activity against Gram-negative pathogens. In Nigeria, quinolones and -lactam antibiotics are widely used as broad-spectrum antibiotics to treat infections caused by various Gram-negative pathogens. Whilst it was initially suggested that susceptibility to quinolones in Nigeria may remain high as these drugs are expensive and beyond the reach of most individuals, their use has increased and there have been sporadic reports of isolates with decreased quinolone susceptibility from Nigeria.
Chromosomal resistance to fluoroquinolones (FQs) due to amino acid substitutions in the quinolone resistance-determining regions (QRDRs) of DNA gyrase (GyrA) and/or topoisomerase IV (ParC) or to efflux pump derepression/alteration in porin expression is well understood [1] . Plasmid-mediated mechanisms of resistance to FQs mediated by Qnr alleles (qnrB, qnrS, qnrC and qnrD), the aac(6')-Ib-cr variant and qepA have been identified from countries around the world [2] . Association of multiple antibiotic resistance genes on mobile genetic elements has been an important mechanism of dissemination of multidrug resistance and may explain in part the frequent association between FQ resistance and resistance to expandedspectrum -lactams in Enterobacteriaceae. In addition, the presence of multiple resistance genes on a plasmid expands the subset of drugs that may select for dissemination of multidrug resistance plasmids. A variety of extended-spectrum -M a n u s c r i p t lactamase (ESBL) enzymes have evolved and have been detected in Gram-negative pathogens in the last 30 years; most recently, the CTX-M group of enzymes have become the dominant ESBL detected worldwide [3] .
In this study, an extremely high level of resistance to multiple antibiotics, including FQs and cephalosporins, was detected amongst a diverse panel of Gram-negative isolates from various Nigerian hospitals. This resistance was underpinned by the carriage of a wide variety of plasmid-borne quinolone resistance alleles and ESBL genes, including the first identification of the qnrD allele outside of China. This work gives a snapshot of the prevalence of antibiotic resistance in Nigeria where antibiotic use is unregulated and little data exist regarding resistance levels in this part of the world. The establishment of a pool of highly resistant strains in Nigeria may act as a reservoir for dissemination of resistant strains to other countries.
Materials and methods

Bacterial Isolates
In a n u s c r i p t (Sagamu). All isolates were identified using API 20E strips (bioMérieux, Marcy l'Etoile, France). 
Determination of antibiotic susceptibility
Genotyping of quinolone-resistance determining regions
The QRDRs of gyrA, gyrB, parC and parE were amplified and mutations were detected using denaturing high-performance liquid chromatography (HPLC) as described previously [4] .
Amplification of antimicrobial resistance genes
Polymerase chain reaction (PCR) was used to detect genes encoding resistance to -lactams (bla OXA , bla SHV , bla TEM , bla CTX-M and bla AmpC ) as well as plasmid-mediated M a n u s c r i p t quinolone resistance (PMQR) genes as previously described [5, 6] . Multiplex PCR was used to amplify variants of qnrA, qnrB and qnrS in one reaction as previously described [6] . New primers were designed for amplification of qnrD (QnrDF, 5' GACAGGAATAGCTTGGAAGG 3'; QnrDR, 5' CTGCTCTCCATCCAACTTCA 3').
Amplimers resulting from these PCR reactions were sequenced to confirm the identity and specific variant of each gene identified and sequences were aligned to known reference sequences using ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
Phenotypic detection of -lactamases
Broth cultures of each test strain as well as ampicillin-resistant E. coli strain NCTC 10418 (carrying pUC18) were incubated overnight in 5 mL of Luria-Bertani broth.
Then, 200 L of the resulting overnight culture was transferred into the wells of a microtitre tray; sterile broth was included as a negative control. Then, 10 L of nitrocefin solution (Fisher Scientific, Loughborough, UK) prepared according to the manufacturer's instructions was added to each well. -Lactamase production was inferred when the broth turned red within 30 min of addition of nitrocefin as directed by the manufacturer.
Detection of extended-spectrum -lactamases by the double-disk diffusion test (DDDT)
Suspensions of each test strain were prepared in sterile water to give an inoculum equivalent to a 0.5 McFarland standard before being used to inoculate the surface of Iso-Sensitest Agar plates [7] . ESBL-positive Klebsiella pneumoniae ATCC 700603 M a n u s c r i p t and ESBL-negative E. coli ATCC 25922 control strains were used in these experiments. A 30 g ceftazidime disk (the best indicator for TEM-and SHV-derived ESBLs) was placed on the left of each plate and a 30 g cefotaxime disk (the best indicator for CTX-M types) was placed on the right; an AMC (20/10 g) (Oxoid Ltd., Basingstoke, UK) was placed in the centre between the other disks. The disks were placed 25-30 mm apart, centre-to-centre. Following overnight incubation in air at 37 C, ESBL production was inferred when the zone of inhibition around the ceftazidime and cefotaxime disks was expanded by ≥5 mm by the presence of clavulanic acid.
Detection of AmpC
AmpC -lactamase production was detected using cefepime and cefpodoxime disks in combination with clavulanic acid as previously described [8] . The plate and the inoculum were essentially the same as for ESBL detection described above.
Following overnight incubation at 37 C, AmpC -lactamases were detected using a difference of ≥14 mm between cefepime/cloxacillin and cefpodoxime/cloxacillin disks.
Results
Antibiotic susceptibility
The MICs for all antibiotics and selected isolates using the agar dilution method are shown in Table 1 . The results showed a high degree of resistance, with MIC 90 values (MIC for 90% of the organisms) of 256 g/mL for all antibiotics. M a n u s c r i p t
Mechanisms of quinolone resistance
As is commonly seen in FQ-resistant mutants, substitutions in the topoisomerase genes gyrA and parC were identified. In total, 92 (68.7%) of the 134 isolates carried a mutation in the QRDR of gyrA or parC; no mutation was detected in gyrB or parE from any of the isolates studied. Mutations in gyrA were found at positions 83 and 87, whilst two substitutions were seen within parC at codons 80 and 87. All parC mutations were seen in strains that also carried a gyrA mutation. Eleven (8.2%) of the isolates carried a qnr gene, all of which had 100% sequence identity to previously described alleles. Five isolates (3.7%) were found to be qnrA1-positive, 3
(2.2%) were found to carry qnrB and 3 (2.2%) carried qnrD, previously only seen in Chinese Salmonella isolates [9] . The qnrD-carrying isolates comprised two Proteus mirabilis and one P. aeruginosa. The qnrS allele was not detected in any isolate.
None of the qnr-positive isolates had more than one qnr gene. Twenty-three (17.2%) of the isolates were positive for aac(6')-Ib-cr, and 6 (54.5%) of the 11 qnr-positive strains also carried aac(6')-Ib-cr. Five isolates (3.7%) were found to carry the qepA efflux pump gene; no qnr or aac(6')-Ib-cr gene was detected in these isolates. The PMQR genes were well distributed among the isolates, hospitals and clinical specimens ( Table 2 ). There were two isolates (L8 and SGm) with reduced FQ resistance (0.06-4 g/mL) but no gyrase or topoisomerase IV mutations: L8 carried aac(6')-Ib-cr; and SGm carried qnrB. All other isolates carrying a PMQR gene also had a topoisomerase mutation(s). M a n u s c r i p t
Mechanisms of -lactam resistance
Of the 134 isolates, 111 (82.8%) were found to produce a -lactamase by the nitrocefin assay; 85.7% of K. pneumoniae subsp. pneumoniae, 71.4% of E. coli, 69.2% of P. aeruginosa and 81.8% of P. mirabilis ( Table 3 ). The rest of the strains were uniformly positive in the nitrocefin reactions. ESBL production was inferred using the DDDT; 28 isolates (20.9%) were found to be ESBL-positive by the DDDT (Table 3 ). Phenotypic detection of AmpC suggested that AmpC enzymes were present in 29 isolates (21.6%). Twenty-five AmpC-positive isolates were detected and were interpreted as positive using an increase of ≥14 mm in zone diameter around the antibiotic disk with added inhibitor compound between cefepime and cefpodoxime. Four further isolates were suspected of possessing an inducible AmpC where a defined increase in zone diameter around the antibiotic disk with added inhibitor compound compared with that with the antibiotic-containing disk alone was observed.
All 134 isolates were tested by PCR for the presence of -lactamase genes. TEM variants were present in 109 isolates (81.3%), SHV variants in 33 (24.6%), OXA variants in 15 (11.2%) and CTX-M variants in 25 isolates (18.7%; 24 of these were CTX-M-15 and 1 isolate carried CTX-M-3); genes of all these groups were present in 6 isolates (4.5%) (data not shown). Multiplex PCR for detection of ampC genes confirmed six isolates as carrying non-chromosomal ampC enzymes and these genes were only found in isolates with CTX-M genes. The ampC-positive strains cut across most of the clinical sites of specimens, ranging from wound to ear, aspirate, blood culture and catheter tip. Of the six ampC-positive genes, one was amplified using EBC group primers, four by DHA group primers and one by CIT primers.
M a n u s c r i p t
Sequencing identified these genes as ACT-1, DHA-1 and CMY-2, respectively. No enzymes belonging to ACC, FOX and MOX families were detected.
Discussion
Isolates were collected for this study without any bias towards resistant strains. All isolates demonstrated an extremely high level of resistance to all the drugs tested, including the FQs for which most strains had MIC values as high as 256 g/mL. There was no difference between the MIC 50 (MIC for 50% of the organisms) and the MIC 90 values of the isolates in this study, and clinical failure of FQ drug therapy is inevitable for strains with such high levels of resistance. Quinolone-resistant strains carried one or more mutations within gyrA and additional mutations within parC, as has commonly been seen in highly FQ-resistant mutants in other studies [1] .
Carriage of a variety of transferable quinolone resistance alleles was detected in these strains, including qnrA1, qnrB, qnrD, aac(6')-Ib-cr and qepA. This demonstrates that these alleles are truly global and have spread to West Africa; qnrD in particular has previously only been described in an isolate from China [9] .
Identification of this allele in these Nigerian isolates of Proteus and Pseudomonas demonstrates its presence in another continent as well as in two species in addition to Salmonella where it was first described. Whether this represents global dissemination of this gene or identification of separate acquisition events from environmental species is unclear and further work is required to clarify this. Six (54.5%) of the eleven qnr-positive strains also carried aac(6')-Ib-cr. Five isolates were detected to be carrying the plasmid-mediated quinolone resistance efflux pump gene qepA; interestingly, four of these isolates did not carry topoisomerase mutations but did demonstrate high-level resistance to quinolones. No other PMQR A c c e p t e d M a n u s c r i p t genes were found in these isolates suggesting that qepA is contributing to this highlevel resistance in these strains.
Of the 134 isolates, 28 (20.9%) were found to carry an ESBL. This rate of ESBL carriage is similar to that seen in other countries and is similar to the few previous reports from Nigeria, where a previous study found 8 (20%) of 40 Enterobacter isolates produced an ESBL by the DDDT [10] . In this study, the predominant ESBL genotype detected was CTX-M-15. There has been an increase in the isolation of CTX-M-producing bacteria in the last 20 years globally and these genes are spread worldwide. In this study, 25 isolates were CTX-M positive, of which 24 were CTX-M-15 and only 1 was CTX-M-3. CTX-M-15 has been described in Nigeria before but this study is the first report of CTX-M-3 in Nigeria.
The presence of ampC genes was indicated for a number of strains phenotypically and was confirmed in six isolates by PCR. These genes were found in isolates coproducing other ESBL genes such as CTX-M, TEM, SHV and OXA genes.
Sequencing identified these genes as ACT-1, DHA-1 and CMY-2. DHA-like enzymes (originally derived from Morganella morganii) were most common [4] in the isolates.
These ampC-positive strains appeared to have low-level resistance to the thirdgeneration cephalosporins used in this study but demonstrated high-level quinolone resistance.
In conclusion, there is a high level of resistance to many antimicrobials in different species of Gram-negative enteric bacilli, most critically to FQs and -lactam Page 20 of 20 A c c e p t e d M a n u s c r i p t
